PM2.5 from biofuel smoke induces inflammatory response through the TRPC6/Ca2+/NLRP3 signaling pathway

Yan Chen1, Na Zhan1, Jinhuang Xu2

  • 1State Key Laboratory of Respiratory Disease, Key Laboratory of Protein Modification and Degradation, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, Guangdong, People's Republic of China.

Insights

Biofuel smoke fine particulate matter (PM2.5) triggers pulmonary inflammation by activating the NLRP3 inflammasome via a TRPC6/Ca2+ pathway in macrophages, offering insights into respiratory disease mechanisms.

Area of Science:

  • Environmental Health
  • Immunology
  • Molecular Biology

Background:

  • Household air pollution from biomass burning is a major cause of pulmonary diseases, linked to fine particulate matter (PM2.5).
  • Pulmonary macrophages are key players in inflammation triggered by PM2.5 exposure.
  • The NLRP3 inflammasome is implicated in inflammatory responses to environmental pollutants.

Purpose of the Study:

  • To investigate the impact of biofuel smoke-derived PM2.5 (BPM2.5) on NLRP3 inflammasome activation in macrophages.
  • To elucidate the role of TRPC6 and intracellular calcium ([Ca2+]i) in BPM2.5-induced inflammation.

Main Methods:

  • Exposure of rats to BPM2.5 and analysis of pulmonary inflammation markers.
  • In vitro studies on macrophages exposed to BPM2.5, assessing NLRP3 inflammasome components and TRPC6 expression.
  • Utilizing Trpc6 knockout macrophages to determine the role of TRPC6 in the inflammatory pathway.

Main Results:

  • BPM2.5 exposure induced significant pulmonary inflammation in rats, with increased neutrophils and macrophages.
  • BPM2.5 upregulated NLRP3 inflammasome components and TRPC6 in macrophages.
  • Trpc6 knockout reversed BPM2.5-induced NLRP3 activation, reduced [Ca2+]i, and suppressed IL-1β and IL-18 release.

Conclusions:

  • BPM2.5 activates the NLRP3 inflammasome through a TRPC6/Ca2+ pathway in macrophages.
  • This pathway contributes to PM2.5-induced pulmonary inflammation.
  • Findings suggest potential therapeutic targets for PM2.5-related respiratory diseases.